1-5 of 5
Zhe-Sheng Chen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The BTK Inhibitor Ibrutinib (PCI-32765) Overcomes Paclitaxel Resistance in ABCB1- and ABCC10-Overexpressing Cells and Tumors

Hui Zhang, Atish Patel, Yi-Jun Wang, Yun-Kai Zhang, Rishil J. Kathawala, Long-Hui Qiu, Bhargav A. Patel, Li-Hua Huang, Suneet Shukla, Dong-Hua Yang, Suresh V. Ambudkar, Li-Wu Fu, Zhe-Sheng Chen
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2017) 16 (6): 1021–1030.
https://doi.org/10.1158/1535-7163.MCT-16-0511
Published: 01 June 2017
View article titled, The BTK Inhibitor Ibrutinib (PCI-32765) Overcomes Paclitaxel Resistance in ABCB1- and ABCC10-Overexpressing Cells and Tumors
Open the PDF for The BTK Inhibitor Ibrutinib (PCI-32765) Overcomes Paclitaxel Resistance in ABCB1- and ABCC10-Overexpressing Cells and Tumors in another window
Includes: Supplementary data
Journal Articles

miR200c Attenuates P-gp–Mediated MDR and Metastasis by Targeting JNK2/c-Jun Signaling Pathway in Colorectal Cancer

Hua Sui, Guo-Xiang Cai, Shu-Fang Pan, Wan-Li Deng, Yu-Wei Wang, Zhe-Sheng Chen, San-Jun Cai, Hui-Rong Zhu, Qi Li
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2014) 13 (12): 3137–3151.
https://doi.org/10.1158/1535-7163.MCT-14-0167
Published: 04 December 2014
View article titled, miR200c Attenuates P-gp–Mediated MDR and Metastasis by Targeting JNK2/c-Jun Signaling Pathway in Colorectal Cancer
Open the PDF for miR200c Attenuates P-gp–Mediated MDR and Metastasis by Targeting JNK2/c-Jun Signaling Pathway in Colorectal Cancer in another window
Includes: Supplementary data
Journal Articles

Masitinib Antagonizes ATP-Binding Cassette Subfamily C Member 10–Mediated Paclitaxel Resistance: A Preclinical Study

Rishil J. Kathawala, Kamlesh Sodani, Kang Chen, Atish Patel, Alaa H. Abuznait, Nagaraju Anreddy, Yue-Li Sun, Amal Kaddoumi, Charles R. Ashby, Jr, Zhe-Sheng Chen
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2014) 13 (3): 714–723.
https://doi.org/10.1158/1535-7163.MCT-13-0743
Published: 09 March 2014
View article titled, Masitinib Antagonizes ATP-Binding Cassette Subfamily C Member 10–Mediated Paclitaxel Resistance: A Preclinical Study
Open the PDF for Masitinib Antagonizes ATP-Binding Cassette Subfamily C Member 10–Mediated Paclitaxel Resistance: A Preclinical Study in another window
Includes: Supplementary data
Journal Articles

Abstract B112: ARRY-334543 reverses multidrug resistance by antagonizing the activity of ATP-binding cassette subfamily G member 2.

De-Shen Wang, Atish Patel, Priyank Kumar, Rui-Hua Xu, Zhe-Sheng Chen
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2013) 12 (11_Supplement): B112.
https://doi.org/10.1158/1535-7163.TARG-13-B112
Published: 01 November 2013
View article titled, Abstract B112: ARRY-334543 reverses multidrug resistance by antagonizing the activity of ATP-binding cassette subfamily G member 2.
Journal Articles

The Novel BCR-ABL and FLT3 Inhibitor Ponatinib Is a Potent Inhibitor of the MDR-Associated ATP-Binding Cassette Transporter ABCG2

Rupashree Sen, Karthika Natarajan, Jasjeet Bhullar, Suneet Shukla, Hong-Bin Fang, Ling Cai, Zhe-Sheng Chen, Suresh V. Ambudkar, Maria R. Baer
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2012) 11 (9): 2033–2044.
https://doi.org/10.1158/1535-7163.MCT-12-0302
Published: 06 September 2012
View article titled, The Novel BCR-ABL and FLT3 Inhibitor Ponatinib Is a Potent Inhibitor of the MDR-Associated ATP-Binding Cassette Transporter ABCG2
Open the PDF for The Novel BCR-ABL and FLT3 Inhibitor Ponatinib Is a Potent Inhibitor of the MDR-Associated ATP-Binding Cassette Transporter ABCG2 in another window